| Title | European Neuropsychopharmacology |
| Abbreviation | Eur. Neuropsychopharmacol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1) |
| h-index | 136 |
| Overall Rank/Ranking | 1538 |
| SCImago Journal Rank (SJR) | 1.934 |
| Impact Score | 4.89 |
| Publisher | Elsevier B.V. |
| Country | Netherlands |
| ISSN | 0924977X, 18737862 |
| Best Quartile | Q1 |
| Coverage History | 1990-2025 |
European Neuropsychopharmacology is a journal covering the technologies/fields/categories related to Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1). It is published by Elsevier B.V.. The overall rank of European Neuropsychopharmacology is 1538. According to SCImago Journal Rank (SJR), this journal is ranked 1.934. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 136. The best quartile for this journal is Q1.
The ISSN of European Neuropsychopharmacology journal is 0924977X, 18737862. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. European Neuropsychopharmacology is cited by a total of 1941 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of European Neuropsychopharmacology is 4.89, which is computed in 2025 as per its definition. European Neuropsychopharmacology IF is increased by a factor of 0.67 and approximate percentage change is 15.88% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of European Neuropsychopharmacology is 4.89. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 4.89 |
| 2023 | 4.22 |
| 2022 | 4.62 |
| 2021 | 4.34 |
| 2020 | 3.66 |
| 2019 | 3.61 |
| 2018 | 4.32 |
| 2017 | 4.10 |
| 2016 | 4.52 |
| 2015 | 4.68 |
| 2014 | 4.44 |
European Neuropsychopharmacology has an h-index of 136. It means 136 articles of this journal have more than 136 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of European Neuropsychopharmacology is 0924977X, 18737862. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of European Neuropsychopharmacology is 1538. According to SCImago Journal Rank (SJR), this journal is ranked 1.934. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.934 |
| 2023 | 1.756 |
| 2022 | 1.442 |
| 2021 | 1.324 |
| 2020 | 1.603 |
| 2019 | 1.652 |
| 2018 | 1.911 |
| 2017 | 1.911 |
| 2016 | 2.085 |
| 2015 | 1.903 |
| 2014 | 2.209 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1538 |
| 2023 | 1708 |
| 2022 | 2283 |
| 2021 | 2601 |
| 2020 | 2014 |
| 2019 | 1872 |
| 2018 | 1483 |
| 2017 | 1494 |
| 2016 | 1281 |
| 2015 | 1593 |
| 2014 | 1155 |
European Neuropsychopharmacology is published by Elsevier B.V.. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 1990-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of European Neuropsychopharmacology is Eur. Neuropsychopharmacol.. This abbreviation ('Eur. Neuropsychopharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
European Neuropsychopharmacology latest impact IF is 4.89. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 4.89 (2024) and 3.61 (2019), respectively, in the last 11 years. Moreover, its average IS is 4.31 in the previous 11 years.
The European Neuropsychopharmacology has an SJR (SCImago Journal Rank) of 1.934, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 2.209 in 2014 and the lowest being 1.324 in 2021. Furthermore, the average SJR of the European Neuropsychopharmacology over the previous 11-year period stands at 4.31.
The latest h-index of the European Neuropsychopharmacology is 136.
The European Neuropsychopharmacology is published by the Elsevier B.V., with its country of publication being the Netherlands.
The European Neuropsychopharmacology is currently ranked 1538 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1155 in 2014 and its lowest position of 2601 in 2021.
The standard ISO4 abbreviation for the European Neuropsychopharmacology is Eur. Neuropsychopharmacol..
European Neuropsychopharmacology is classified as a journal that the Elsevier B.V. publishes.
The European Neuropsychopharmacology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The European Neuropsychopharmacology is assigned the following International Standard Serial Numbers (ISSN): 0924977X, 18737862.
The best quartile for the European Neuropsychopharmacology is Q1 (2024).
The European Neuropsychopharmacology coverage history can be summarized as follows: 1990-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Field Archaeology | journal | 7683 | Maney Publishing | 48 | 1.85 |
| Applied Ecology and Environmental Research | journal | 19122 | Corvinus University of Budapest | 48 | 0.84 |
| Qualitative Research | journal | 1300 | SAGE Publications Ltd | 101 | 6.77 |
| Clinical Medicine and Research | journal | 14921 | Marshfield Clinic | 64 | 1.25 |
| Entrepreneurship Theory and Practice | journal | 168 | SAGE Publications Ltd | 212 | 13.35 |
| Archives of Phytopathology and Plant Protection | journal | 16692 | Taylor and Francis Ltd. | 35 | 1.42 |
| Materials Research | journal | 15597 | Universidade Federal de Sao Carlos | 75 | 1.40 |
| Abacus | journal | 11890 | Wiley-Blackwell Publishing Ltd | 56 | 2.95 |
| Journal, Indian Academy of Clinical Medicine | journal | 28559 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Tekstilec | trade journal | 17340 | University of Ljubljana Press | 16 | 1.29 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 4.89 |
| 2023 | 4.22 |
| 2022 | 4.62 |
| 2021 | 4.34 |
| 2020 | 3.66 |
| 2019 | 3.61 |
| 2018 | 4.32 |
| 2017 | 4.10 |
| 2016 | 4.52 |
| 2015 | 4.68 |
| 2014 | 4.44 |
